Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) Enterprise Value (EV): $15.94B

The enterprise value (EV) for Hologic, Inc. (HOLX) is $15.94B as of Tuesday, June 9, 2026.

HOLX Enterprise Value (EV) Metrics

ENTERPRISE VALUE (EV)

$15.94B

HOLX Competitors' Enterprise Value (EV)

NAMEMARKET CAPENTERPRISE VALUE (EV)
Hologic, Inc. (HOLX)$15.94B
Moderna, Inc. (MRNA)$18.94B$10.79B
Align Technology, Inc. (ALGN)$12.76B$10.36B
BioNTech SE (BNTX)$21.87B$12.18B
Mettler-Toledo International Inc. (MTD)$23.50B$31.01B
Waters Corporation (WAT)$24.19B$23.51B
Charles River Laboratories International, Inc. (CRL)$9.14B$12.95B
Bio-Rad Laboratories, Inc. (BIO)$8.03B$9.26B
Veeva Systems Inc. (VEEV)$27.37B$32.05B
Hims & Hers Health, Inc. (HIMS)$6.46B$8.34B

Enterprise Value Calculation

Market Cap

$16.97B

+

Total Debt

$2.51B

Cash

$1.96B

=

Enterprise Value

$15.94B

EV-Based Valuation Multiples

Why use EV instead of Market Cap?

  • EV accounts for debt - an acquirer must pay or assume it
  • EV deducts cash - the acquirer effectively receives it
  • EV enables fair comparison of companies with different capital structures
  • EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral

Hologic, Inc. Enterprise Value (EV) Formula & Definition

Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Hologic, Inc. Enterprise Value (EV) FAQ

What is the enterprise value (EV) for Hologic, Inc. (HOLX)?
The enterprise value (EV) for HOLX stock is $15.94B.

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini